450 related articles for article (PubMed ID: 31261440)
21. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
22. Overall and subgroup prevalence of acne vulgaris among patients with hidradenitis suppurativa.
Wertenteil S; Strunk A; Garg A
J Am Acad Dermatol; 2019 May; 80(5):1308-1313. PubMed ID: 30287328
[TBL] [Abstract][Full Text] [Related]
23. Features of Patients With Crohn's Disease and Hidradenitis Suppurativa.
Kamal N; Cohen BL; Buche S; Delaporte E; Colombel JF
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):71-9. PubMed ID: 25956836
[TBL] [Abstract][Full Text] [Related]
24. Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis.
Rodríguez-Zuñiga MJM; García-Perdomo HA; Ortega-Loayza AG
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):279-288. PubMed ID: 30846164
[TBL] [Abstract][Full Text] [Related]
25. Hidradenitis suppurativa and associated diseases.
Pescitelli L; Ricceri F; Prignano F
G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):8-17. PubMed ID: 30468375
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
27. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis.
Bozdag G; Mumusoglu S; Zengin D; Karabulut E; Yildiz BO
Hum Reprod; 2016 Dec; 31(12):2841-2855. PubMed ID: 27664216
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.
Phan K; Tatian A; Woods J; Cains G; Frew JW
Int J Dermatol; 2020 Feb; 59(2):221-228. PubMed ID: 31631340
[TBL] [Abstract][Full Text] [Related]
29. Anemia in patients with hidradenitis suppurativa : A systematic review with meta-analysis.
Revankar R; Rojas M; Walsh S; Patel H; Revankar N; Han J; Parameswaran A
Arch Dermatol Res; 2023 Aug; 315(6):1639-1648. PubMed ID: 36781458
[TBL] [Abstract][Full Text] [Related]
30. Hidradenitis suppurativa and acne conglobata associated with spondyloarthropathy.
Leybishkis B; Fasseas P; Ryan KF; Roy R
Am J Med Sci; 2001 Mar; 321(3):195-7. PubMed ID: 11269796
[TBL] [Abstract][Full Text] [Related]
31. Two diseases one remedy? Systemic amyloidosis secondary to hidradenitis suppurativa: Treatment with infliximab.
Özer İ; Karaçin C; Adışen E; Güz G; Ali Gürer M
Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 27862787
[TBL] [Abstract][Full Text] [Related]
32. Risk of metabolic syndrome in adolescents with polycystic ovarian syndrome: A systematic review and meta-analysis.
Fazleen NE; Whittaker M; Mamun A
Diabetes Metab Syndr; 2018 Nov; 12(6):1083-1090. PubMed ID: 29789222
[TBL] [Abstract][Full Text] [Related]
33. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis.
Phan K; Charlton O; Smith SD
Clin Exp Dermatol; 2019 Jun; 44(4):e126-e132. PubMed ID: 30730068
[TBL] [Abstract][Full Text] [Related]
34. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
35. Lichen sclerosus and hidradenitis suppurativa: Two case reports of a new possible association.
Moliterni E; Miraglia E; Iacovino C; Bianchini D; Giustini S
Australas J Dermatol; 2021 Feb; 62(1):e92-e94. PubMed ID: 32815154
[TBL] [Abstract][Full Text] [Related]
36. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
37. Gluteal hidradenitis suppurativa presenting pemphigus-like findings: case report.
Kurihara Y; Furue M
BMC Dermatol; 2019 Jul; 19(1):11. PubMed ID: 31337387
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
[TBL] [Abstract][Full Text] [Related]
39. Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome).
Melibary YT
Dermatol Reports; 2018 Apr; 10(1):7546. PubMed ID: 29991979
[TBL] [Abstract][Full Text] [Related]
40. Association between biochemical hyperandrogenism parameters and Ferriman-Gallwey score in patients with polycystic ovary syndrome: A systematic review and meta-regression analysis.
Amiri M; Ramezani Tehrani F; Nahidi F; Bidhendi Yarandi R; Behboudi-Gandevani S; Azizi F
Clin Endocrinol (Oxf); 2017 Sep; 87(3):217-230. PubMed ID: 28575537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
